News
-
Dec 05, 2025NKF's Propofol Injectable Emulsion has been approved by the US FDA and is about to enter the US market!Learn More
-
Dec 03, 2025NKF's subsidiary Kindos's Dalbavancin for Injection gets FDA approval for marketingLearn More
-
Oct 21, 2025NKF sincerely invites global customers to gather at CPHI Europe to explore new opportunities for cooperation together!Learn More
-
Company NewsNKF attended the 25th anniversary celebration of GMS in Pakistan to deepen strategic cooperation
Oct 17, 2025 -
Company NewsNKF's subsidiary Kindos's Etoposide Injection gets FDA approval for marketing
Aug 04, 2025 -
Company NewsNKF makes its debut at CPHI Southeast Asia
Jul 21, 2025 -
Company NewsKing-Friend will meet you in CPHI Malaysia！
Jul 14, 2025 -
Company NewsNKF's subsidiary Kindos's Hydralazine Hydrochloride Injection gets FDA
Jun 09, 2025
